CVR: 40794492
KeasClinical Studies ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lone Bliksted Gitz-Johansen. The company is owned by Mette Albinus Grønbæk and Blitz Holding ApS. In 2025, the company reported a gross profit of DKK -23,492 and a net result of DKK -14,372 compared with DKK -607 the year before. Equity amounted to DKK 78,298.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed indenfor kliniske studier og anden dermed i forbindelse stående virksomhed.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.164 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
KeasClinical Studies ApS has published its annual report for 2025. Gross profit came to DKK -23,492, and the net result was DKK -14,372.
KeasClinical Studies ApS has published its annual report for 2024. Gross profit came to DKK -658, and the net result was DKK -607.
As of September 24, 2024, Mette Albinus Grønbæk is registered as an owner of KeasClinical Studies ApS with an ownership share of 5%.
As of September 24, 2024, Blitz Holding ApS is registered as an owner of KeasClinical Studies ApS with an ownership share of 90%.
As of August 31, 2024, Lone Bliksted Gitz-Johansen is registered as director of KeasClinical Studies ApS.
As of August 31, 2024, Janus Bliksted Gitz-Johansen has stepped down as director of KeasClinical Studies ApS.
KeasClinical Studies ApS has published its annual report for 2023. Gross profit came to DKK -7,500, and the net result was DKK -7,486.
KeasClinical Studies ApS has published its annual report for 2022. Gross profit came to DKK -23,277, and the net result was DKK -10,427.
KeasClinical Studies ApS has published its annual report for 2021. Gross profit came to DKK 150,954, and the net result was DKK 112,829.
KeasClinical Studies ApS has published its interim report for the period September 18, 2019 – December 31, 2020.
As of September 18, 2019, Janus Bliksted Gitz-Johansen is registered as director of KeasClinical Studies ApS.
KeasClinical Studies ApS was founded on September 18, 2019.
Companies in the same industry and area
CVR 45091988
CVR 33820852
CVR 46311590
CVR 42824461
CVR 13381046
companydata.dk